Chief Executive Officer, Agility Health Tech
Having taken a range of therapeutic products through clinical Phases 1 to 3, she thrives on translating innovative technologies into healthcare products and shaping technical and organisational strategies. She was honoured with the Royal Pharmaceutical Society’s Pharmaceutical Science Award in 2015, and the Academy of Pharmaceutical Sciences’ Medal in 2016.
Before founding Agility Health Tech, she was Head of R&D with Oxford PharmaScience, an AIM-listed virtual Pharmaceutical company identified as one of the “Top 10 Emerging Technology Companies 2012”. Prior to this, Claire was Associate Director at Molecular Profiles (now Juniper Pharmaceuticals) and spent 7½ years at GlaxoSmithKline and Pfizer developing novel molecules and formulations for therapeutic areas such as asthma, cancer, HIV, insomnia, malaria and pain.
16 November 2020
BOOK YOUR PLACE NOW